Press Releases

Almac Discovery has announced a £13million partnership with the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast (QUB) to accelerate cancer-focused drug discovery in Northern Ireland. As part of the partnership,...

PharmaEngine Inc.  announced today that together with PharmaEngine’s partner Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) we reach the goal of patient enrollment in the global phase 3 metastatic pancreatic cancer study of PEP02 (MM-398). The total target number of patient...

Infraredx Inc. a medical device company committed to advancing the diagnosis and management of coronary artery disease today announced that it has received a $25 million equity investment from Nipro Corporation. This investment builds on...

Research by Cutting Edge Information finds that intellectual property protections in the United States encourage more pharmaceutical drug launches relative to other countries with weaker protections. According to Cutting Edge Information’s study “Pharmaceutical Launch Sequencing:...

The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today applauded European approval of pomalidomide the newest drug for multiple myeloma treatment. ...

AmpliPhi BioSciences Corp. (“AmpliPhi”) the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th...

MedPharm Ltd the topical drug development specialist today announced it has been granted a series of further patents for its novel MedSpray®topical spray-on-film technology for dermatological topical and transdermal drug delivery. The North American drug...